Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy.

Min Kyeong JangSeho ParkChang ParkArdith DoorenbosJieon GoSue Kim

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)

Our findings of higher anemia prevalence in breast cancer patients with sarcopenia and decreased SMI and SFI after neoadjuvant chemotherapy provide evidence of a relationship between anemia and body composition change. Early screening and combined consideration of body composition change, sarcopenia status, and chemotherapy regimen could improve clinical outcomes.

Keyphrases

body composition
neoadjuvant chemotherapy
locally advanced
resistance training
bone mineral density
sentinel lymph node
lymph node
skeletal muscle
rectal cancer
squamous cell carcinoma
chronic kidney disease
radiation therapy
community dwelling
iron deficiency
risk factors
early stage
postmenopausal women